BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Nicolet Bankshares
NIC
$3.65B
| $50.1M | ﹤0.01% |
711,569
-67,846
| -9% | -$5.29M |
|
2702
York Water
YORW
$500M
| $50M | ﹤0.01% |
1,103,102
-17,357
| -2% | -$861K |
|
2703
Akebia Therapeutics
AKBA
$346M
| $49.9M | ﹤0.01% |
13,174,681
+805,695
| +7% | +$2.71M |
|
|
ASXC
2704
DELISTED
Asensus Surgical, Inc.
ASXC
| $49.8M | ﹤0.01% |
15,707,051
+13,197,435
| +526% | +$33M |
|
2705
DigitalOcean
DOCN
$14.6B
| $49.7M | ﹤0.01% |
894,719
+864,719
| +2,882% | +$37.3M |
|
2706
Ennis
EBF
$562M
| $49.7M | ﹤0.01% |
2,310,244
+7,523
| +0.3% | +$159K |
|
2707
Anterix
ATEX
$1.94B
| $49.7M | ﹤0.01% |
828,458
-2,645
| -0.3% | -$133K |
|
2708
ASE Group
ASX
$80.9B
| $49.6M | ﹤0.01% |
6,161,922
+4,567,552
| +286% | +$36.7M |
|
2709
Verastem
VSTM
$516M
| $49.6M | ﹤0.01% |
1,014,630
-125,986
| -11% | -$5.25M |
|
|
ZEUS
2710
DELISTED
Olympic Steel
ZEUS
| $49.4M | ﹤0.01% |
1,681,107
+21,731
| +1% | +$685K |
|
|
HAAC
2711
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
| $49.4M | ﹤0.01% |
4,932,330
-17,670
| -0.4% | -$180K |
|
|
SPNE
2712
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $49.3M | ﹤0.01% |
2,402,510
+468,628
| +24% | +$9.63M |
|
2713
RPC Inc
RES
$1.28B
| $49.2M | ﹤0.01% |
9,949,028
+166,939
| +2% | +$900K |
|
|
CARM
2714
DELISTED
Carisma Therapeutics
CARM
| $49.2M | ﹤0.01% |
532,891
+386,769
| +265% | +$24.7M |
|
|
ECOM
2715
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $49.1M | ﹤0.01% |
2,003,287
-91,253
| -4% | -$2.19M |
|
2716
iShares MSCI United Kingdom ETF
EWU
$4.14B
| $49.1M | ﹤0.01% |
1,501,057
-5,634,215
| -79% | -$187M |
|
2717
Precision BioSciences
DTIL
$193M
| $48.9M | ﹤0.01% |
130,319
-9,884
| -7% | -$2.97M |
|
2718
CALL
Nucor
NUE
$62.6B
| $48.9M | ﹤0.01% |
+509,700
| New | +$47.7M |
|
2719
Crinetics Pharmaceuticals
CRNX
$8.91B
| $48.9M | ﹤0.01% |
2,593,386
+426,878
| +20% | +$7.5M |
|
2720
DHT Holdings
DHT
$2.88B
| $48.4M | ﹤0.01% |
7,450,958
+1,052,888
| +16% | +$6.46M |
|
2721
Peapack-Gladstone Financial
PGC
$822M
| $48.3M | ﹤0.01% |
1,555,516
-137,110
| -8% | -$4.42M |
|
2722
First Community Bankshares
FCBC
$917M
| $48.3M | ﹤0.01% |
1,618,793
-42,360
| -3% | -$1.28M |
|
2723
Vanguard Morningstar Small-Cap ETF
VB
$81.6B
| $48.3M | ﹤0.01% |
214,468
+51,006
| +31% | +$11.3M |
|
|
TCRR
2724
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $48.2M | ﹤0.01% |
2,937,118
-129,518
| -4% | -$2.62M |
|
|
SP
2725
DELISTED
SP Plus Corporation
SP
| $48.2M | ﹤0.01% |
1,574,121
-191,592
| -11% | -$6.27M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.